Why the study?
Does atropine abolish Wenckebach-type atrioventricular block and prevent Stokes-Adams attacks in a patient with severe coronary artery disease?
Does atropine abolish Wenckebach-type atrioventricular block and prevent Stokes-Adams attacks in a patient with severe coronary artery disease?
Atropine successfully reversed chronic Wenckebach-type AV block and prevented syncope in a patient with severe coronary artery disease.
May support atropine for Wenckebach AV block with Stokes-Adams in CAD; hypothesis-generating from single case report.
A patient with severe angina pectoris and congestive heart failure had chronic Wenckebach-type atrioventricular block and episodes of syncope. Atropine abolished the block and prevented the Stokes-Adams attacks. Carotid sinus pressure, digoxin, and exercise increased the block; atropine prevented these effects.
No takes yet. Share an insight, caveat, or question.
Jick et al. (1959) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: